GGrantIndex
Sort

85,873 grants matching alzheimers

Johns Hopkins-Tufts Trial Innovation Center

$2,869,346
Daniel F Hanley · Johns Hopkins University · U24 · FY2021 · TR

Effect of APOE on CNS Neurons: Role of LRP

$2,868,920
David M Holtzman · Washington University · RF1 · FY2025 · NS

Risk Factors, Pathology, and Clinical Expressions of AD

$2,868,751
David A Bennett · Rush University Medical Center · R01 · FY2024 · AG

NATIONAL NEUROHIV TISSUE CONSORTIUM (NNTC) - CLINICAL SITE - Alzheimer's disease

$2,863,950
Vactor Hadijah · Icahn School Of Medicine At Mount Sinai · N01 · FY2025 · MH

Quantitative Genetic Models for Exploring Missing Heritability of Alzheimer's Disease

$2,863,784
Michael Philip Epstein · Emory University · RF1 · FY2020 · AG

Modeling effects of cadmium exposure on Alzheimer’s Disease pathology and neurodegeneration

$2,862,804
Benjamin Neal Combs · Henry Ford Health + Michigan State University Health Sciences · RF1 · FY2025 · AG

Capillary hyperemia in white matter: Novel mechanistic insight and effect of hypertension and aging

$2,862,305
Maiken Nedergaard · University Of Rochester · RF1 · FY2018 · NS

Estrogens, Cardiometabolic Health, and Female Cognitive Aging

$2,860,477
Jill M Daniel · Tulane University Of Louisiana · P01 · FY2023 · AG

The Alzheimer Disease Sequence Analysis Collaborative

$2,860,386
Jonathan L. Haines · Case Western Reserve University · U01 · FY2022 · AG

Glymphatic and cognitive impairment of aging and diabetes

$2,859,047
Quan Jiang · Henry Ford Health System · RF1 · FY2017 · AG

Study to Uncover Pathways to Exceptional Cognitive Resilience in Aging (SUPERAging)

$2,858,489
Emily J Rogalski · University Of Chicago · U19 · FY2025 · AG

Modulation Of Neuronal Channels and Receptors in the Brain

$2,854,957
Jerrel L Yakel · National Institute Of Environmental Health Sciences · ZIA · FY2018 · ES

Presenilin Biology and Mechanism of Alzheimer's Disease

$2,854,214
Dennis J Selkoe · Brigham And Women'S Hospital · P01 · FY2006 · AG

Detection of cryptic exons (splicing differences) in TDP-43 as biomarkers for frontotemporal dementia and Alzheimer's disease

$2,853,608
Andrew Singleton · National Institute On Aging · ZIA · FY2022 · AG

Generation of Human iPSC-derived Entorhinal Cortex Neurons for Probing Selective Neuronal Vulnerability in Alzheimer's Disease

$2,853,240
Jean-Pierre Roussarie · Rockefeller University · RF1 · FY2017 · AG

Biological basis of post-delirium cognitive decline

$2,853,240
Jaime Grutzendler · Yale University · RF1 · FY2017 · AG

Estrogens, Cardiometabolic Health, and Female Cognitive Aging

$2,853,073
Jill M Daniel · Tulane University Of Louisiana · P01 · FY2024 · AG

DATA CORE (DC)

$2,852,722
Ronald G. Thomas · University Of California, San Diego · U01 · FY2010 · AG

Presenilin Biology and Mechanism of Alzheimer's Disease

$2,850,456
Dennis J Selkoe · Brigham And Women'S Hospital · P01 · FY2007 · AG

GE Healthcare Discovery MR750 3T MRI System

$2,848,680
Frank Korosec · University Of Wisconsin-Madison · S10 · FY2010 · RR

Duke/UNC Alzheimer's Disease Research Center

$2,846,771
Heather E. Whitson · Duke University · P30 · FY2025 · AG

LRP4 deficiency in Alzheimer's disease development

$2,846,666
Wen-Cheng Xiong · Case Western Reserve University · RF1 · FY2020 · AG

A Phase 3 Pivotal Trial of AGB101 to Slow Progression in MCI due to Alzheimer's Disease

$2,844,834
Richard C. Mohs · Agenebio, Inc. · R01 · FY2021 · AG

PET Measures of CSF Clearance in Preclinical Alzheimer's Disease

$2,844,776
Mony J. De Leon · Weill Medical Coll Of Cornell Univ · RF1 · FY2017 · AG

Circuit-specific cell types in aging and Alzheimer's disease

$2,844,527
Kuo-Fen Lee · Salk Institute For Biological Studies · U01 · FY2023 · AG